Blog

TVALA Drug Trial

We are happy to announce the first patients are being screened for entry into the clinical trial for our drug TVALA! This Phase 1 study...

Mar 5, 20241 min read

We are hopeful that TVALA will reduce p53 expression in people with ALS. There are two recent publications that give us hope. The first...

Dec 19, 20232 min read

Pharmacological Characterization of FC-12738: A Novel Retro-Inverso Pentapeptide for Treating Neuroinflammation

Dec 1, 20231 min read

Neurodegenerative disease research is pleased to announce the progress of developing TVALA for the treatment of neuroinflammation in ALS....

Aug 10, 20231 min read

https://www.houstonmethodist.org/leading-medicine-blog/articles/2022/sep/first-biomarkers-identified-to-measure-als-disease-progression-a...

Mar 21, 20231 min read

The preprint manuscript Assessment of levamisole HCl and thymosin α1 in two mouse models of amyotrophic lateral sclerosis by David R...

Jan 24, 20231 min read

NDR would like to congratulate Dr. Susanne Petri and her research team on their recent paper Altered Immunomodulatory Responses in the...

Dec 8, 20221 min read

Dr. Chandler Walker, associate professor in the Department of Biomedical Sciences and Comprehensive Care at Indiana University School of ...

Nov 9, 20221 min read